Headline
UK small-cap earnings skew positive with multiple guidance raises, but ABDP's downgrade and STAF's temp-hours acceleration point to a bifurcated demand picture.
What UK Plc said today
The only guidance cut came from ABDP, which lowered FY26 revenue to £90-95m, citing customers "lengthening procurement decision timelines" amid geopolitical disruption. Against that, guidance was raised at EMR (adj. PBT ≥£5.2m, ~27% above forecast), LUCE (FY27 op profit to exceed expectations; Energy Transition +c.120% YoY), INCH (adj. EPS growth >10%, buyback lifted £175m→£250m) and HKLD (FY underlying profit upgrade). JNEO flagged revenue "marginally ahead" (H1 +53% to £37.6m). Tone across trading updates skewed "ahead" or "in line": GEMD (+33%), NCYT (+18%), PCIP (+9%), DOTD (+8% with ARR +18%), CREO (+45%), WKS (≥20%).
Interim results were broadly constructive. EMG delivered core net revenue $853m (+41%), core EPS +105%, AUM at a record $253.6bn. BOY posted +6.5% organic growth with margins +110bps and reaffirmed FY. UTG reaffirmed 41.5-43.0p EPS guidance despite a statutory loss. Micro-caps DSW and HSM were softer, HSM warning "much uncertainty looking forward" with orders down.
Two names offered mixed signals: SSPG flagged APAC/EEME passenger contraction from the Middle East conflict but held guidance; GMR noted UK gaming revenues +3% despite Remote Gaming Duty rising to 40% on 1 April 2026.
Statistical releases
No scheduled ONS releases today.
Policy / monetary
Nothing from BoE. From HMT, two administrative items: an exposure draft consultation on IFRS 18 application across Central Government, and DAO 07/26 correspondence on sharing information covered by injunctions. Neither is market-moving.
Themes
Middle East as a live P&L input. SSPG cited Iran-linked APAC/EEME passenger contraction; FLO flagged Middle East-driven supply chain and inflation pressure; HSM linked residential softness to regional tensions; ASL managers referenced March's -12% small-cap correction ("fifth worst month in 35-year history") tied to the war in Iran. The dispersion is that operators are trading through it while sentiment/valuations have not fully re-rated.
Capital returns dominate the C-tier. INCH raised its buyback to £250m; SMIN running a £700m tranche of a £1.5bn programme; BOY £80m authorised with £12.6m deployed; UTG £165m executed; EMG $29m of $50m done; STAF has retired ~30% of shares since 2023. Boards are voting with cash on their own valuations.
Guidance raises cluster in specialist industrial/asset-light. EMR, LUCE, INCH, JNEO, HKLD — the common thread is niche positioning (energy transition, distribution rights, premium real estate) rather than broad cyclical recovery. Consistent with ABDP's complaint that broader capex decisions are stalling.
AI/defence pivot continues at the smallcap end. ALRT delivered nil revenue but signed its first MoD contract post year-end; TAVI acquired Plus Group for AI agent tech in financial advice. Early-stage, not yet a earnings story.
Watch
- CMCL Q2 2026 results on 10 August 2026
- CNC interims 6M-Jun 2026 (analyst briefing 7 September, retail webinar 11 September 2026)
- CSC CEO Chris Walters steps down 31 July 2026
- RST CEO handover to Dan Baker effective 1 January 2027
- HKLD Tomorrow's CENTRAL US$1bn transformation and Westbund Shanghai Phase 2 remain the multi-year swing factors